Montelukast to Prevent Liver Enzyme Rise in Dengue
Treatments studied
Part of Infections clinical trials.
This trial tests if montelukast (a common asthma and allergy medicine) can help prevent liver enzyme increases in adults hospitalized with dengue fever. It may be a good option if you have typical dengue and are not too sick.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed dengue infection (by a blood test).
- You must be admitted to the hospital.
- You cannot have serious liver damage or high liver enzymes (above 150 U/L).
- You cannot be pregnant, allergic to certain pain medicines, or have other serious health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
This trial tests whether a new medicine called CP-COV03 can help people recover faster from dengue fever or dengue-like illness. You would receive either the study medicine or a placebo (inactive pill) and be monitored closely to see if symptoms improve.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.